Recent exceptional positive changes in investment behavior have benefitted Orthofix Medical Inc (NASDAQ: OFIX): the stock’s recent price rise disrupted its longer term downtrend, its longer term price trend turned up, and its shorter term price trend turned up.
Orthofix Medical Inc (NASDAQ: OFIX) has benefited from limited positive changes in fundamentals. Positive developments: the stock’s power rating rose above 70, and significant quarterly sales acceleration occurred. Negative development: significant quarterly earnings deceleration occurred.
In light of these very positive signals we are reviewing our current Overall Rating of C. We would view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
OFIX is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
Orthofix Medical has a current Value Trend Rating of C (High Neutral). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Orthofix Medical has a neutral Appreciation Score of 46 but a good Power Rating of 70, leading to the High Neutral Value Trend Rating.
Recent Price Action
Orthofix Medical Inc (NASDAQ: OFIX) stock declined modestly by -1.6% on 6/28/24. The stock closed at $13.26. This decline was accompanied by normal trading volume. The stock has risen 4.4% during the last week and has been strong relative to the market over the last nine months.
Be the first to comment